Saturday 17 October 2026
Export SINT’s income statement to Excel — free account
SINTX TECHNOLOGIES, INC.
SINT Healthcare Medical Devices
SINTX TECHNOLOGIES, INC.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, down 64.7% from fiscal 2024. In the quarter to June 2026, revenue grew 199.3%, EPS grew 17.6%, free cash flow fell 38.6% and total debt fell 6.42%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.74
0.03
−1.69%
Follow SINT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 22.08 |
+8 more quarters Free account |
P/S ratio |
6.82 | 9.75 | 10.52 | 9.54 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(3.28) | (4.03) | (4.57) | (4.82) | |
P/B ratio |
1.88 | 11.10 | 3.66 | 2.98 | |
Price to Tangible BV |
2.06 | 21.40 | 4.31 | 3.35 | |
EV/Sales |
4.21 | 8.03 | 6.47 | 4.68 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.55) | (0.85) | (0.77) | (0.81) | |
EV/FCF |
(0.54) | (0.86) | (0.78) | (0.81) | |
Quick Ratio |
1.32 | 0.54 | 1.16 | 1.47 | |
Current Ratio |
2.36 | 1.04 | 1.51 | 1.70 | |
Net Debt/EBITDA |
1.28 | 0.58 | 1.92 | 1.94 | |
Debt/Assets |
0.98% | 1.36% | 0.07% | 0.52% | |
Debt/Equity |
0.02 | 0.12 | 0.00 | 0.01 | |
Asset Turnover |
0.14 | 0.11 | 0.11 | 0.11 | |
Operating CF/Net income |
0.76 | 0.88 | 1.06 | 0.25 | |
Capex/Depreciation |
(0.55) | (0.04) | (0.26) | (0.53) | |
Interest Coverage |
(1,444.00) | (267.25) | (193.17) | (258.08) | |
Research and Development Expense of Revenue |
126.77% | 95.79% | 334.14% | 607.69% | |
Selling, General and Administrative Expense of Revenue |
573.23% | 772.11% | 518.28% | 1,038.94% | |
Intangible Assets out of Total Assets |
0.04 | 0.06 | 0.05 | 0.04 | |
Share Based Compensation of Revenue |
78.10% | 139.47% | 224.48% | 426.92% | |
Graham Net Nets |
0.16 | (0.26) | (0.09) | 0.01 | |
Graham Number |
0.00 | 0.00 | 0.00 | 2.39 | |
Earnings Yield |
(280.50%) | (216.21%) | (155.32%) | 4.53% | |
Free Cash Flow Yield |
(114.54%) | (95.59%) | (79.00%) | (60.57%) | |
Revenue per Share |
0.09 | 0.09 | 0.10 | 0.07 | |
Operating CF per Share |
(0.57) | (0.62) | (0.85) | (0.85) | |
Capex per Share |
(0.02) | 0.00 | (0.02) | (0.03) | |
Free Cash Flow per Share |
(0.59) | (0.62) | (0.86) | (0.88) | |
Cash per Share |
0.74 | 0.47 | 1.49 | 2.11 | |
Shareholders Equity per Share |
1.00 | 0.23 | 1.06 | 1.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.00 | 0.23 | 1.06 | 1.37 | |
Free Cash Flow |
(2.85) | (2.50) | (2.39) | (2.60) | |
Working Capital |
4.05 | 0.15 | 1.92 | 3.05 | |
Capital Expenditures |
(0.08) | (0.01) | (0.04) | (0.08) | |
Net Current Asset Value |
1.43 | (2.58) | (0.93) | 0.10 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.19 | 0.02 | 0.14 | 0.40 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.21 | 0.23 | 0.19 | 0.23 | |
Average Payables |
0.56 | 0.50 | 0.34 | 0.18 | |
Average Inventory |
1.30 | 0.91 | 0.66 | 0.46 | |
Average Assets |
9.81 | 9.63 | 9.46 | 11.33 | |
Average Common Equity |
4.41 | 3.50 | 3.41 | 4.82 |
Columns are period end dates